Phase 2 study for people with Crohn's Disease and Colitis

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Takeda
Registry number NCT06233461
Started 5 March 2024 Today 16 October 2026 Estimated completion 17 February 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Concord Repatriation General Hospital Concord NSW Recruiting
Mater Cancer Care Centre-Mater Health Services South Brisbane QLD Recruiting
Flinders Medical Centre Bedford Park SA Recruiting
The Queen Elizabeth Hospital Woodville SA Recruiting
Western Health/Footscray Hospital Footscray VIC Recruiting
Harry Perkins Medical Research Institute Fiona Stanley Hospital Murdoch WA Recruiting
Royal Perth Hospital Perth WA Recruiting
Northern Hospital Epping Epping VIC Recruiting
Sir Charles Gairdner Hospital (SCGH) - Comprehensive Cancer Centre Nedlands WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 75 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 268

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Male or female aged 18-75 years old with diagnosis of CD for at least 30 days. In South Korea, the age requirement for adult participants is \>=19 years of age.

2. Confirmed diagnosis of moderately to severely active CD assessed by SES-CD and CDAI.

3. Participants must have had an inadequate response to, loss of response to, or intolerance to at least one or more conventional, biologic, or advanced therapy for CD.

Exclusion Criteria:

1. Participants with indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, radiation colitis, and diverticular disease associated with colitis, and/or ulcerative colitis.

2. Have complications of CD that might require surgery during the study.

3. Participants with a current ostomy.

4. Participants who have failed 3 or more classes of advanced therapies.

Dates on the record

Started 5 March 2024
Estimated completion 17 February 2027
Registry last updated 25 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 25 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.